Side-by-side comparison of AI visibility scores, market position, and capabilities
Chicago Mid-Atlantic/Midwest regulated utility (NASDAQ: EXC) ~$21.6B FY2024 revenue; ComEd/PECO/BGE/Pepco/Delmarva/ACE 10.2M customers, $34.5B capex 2024-2027, Constellation spinoff 2022 competing with PSEG and Dominion.
Exelon Corporation is a Chicago, Illinois-based regulated electric and gas utility holding company — publicly traded on the NASDAQ (NASDAQ: EXC) as an S&P 500 Utilities component — serving approximately 10.2 million electric and gas customers across six regulated utilities: Commonwealth Edison (ComEd — Chicago and Northern Illinois), PECO Energy (Philadelphia and southeastern Pennsylvania), BGE (Baltimore Gas and Electric — Baltimore metro), Pepco (Washington DC and suburban Maryland), Delmarva Power (Delaware and Eastern Shore), and Atlantic City Electric (southern New Jersey) through approximately 21,000 employees. In fiscal year 2024, Exelon reported revenues of approximately $21.6 billion and adjusted EPS of $2.40, as the company managed through its first full year as a pure-play regulated utility following the February 2022 separation of Constellation Energy (the competitive nuclear generation business) as an independent public company — Exelon retaining only the regulated utility distribution and transmission subsidiaries serving Mid-Atlantic and Midwest metropolitan areas. CEO Calvin Butler (joined as CEO in November 2022) leads Exelon's strategy of executing the regulated utility capital plan: $34.5 billion in capital investment over 2024-2027 for distribution system upgrades, grid modernization, electric vehicle charging infrastructure, and regulatory compliance investments across the six utility service territories. Exelon's Mid-Atlantic service territory (Washington DC, Baltimore, Philadelphia, and Chicago) includes the densest concentration of federal government facilities, healthcare systems, and university campuses in the US — creating anchor commercial customers with high-reliability requirements that support premium rate case arguments.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.